DNA vaccines prime CD8+ T cell responses to epitopes of viral antigens produced from overlapping reading frames of a single coding sequence

European Journal of Immunology

Volumn 35, Issue 1, 2005, Pages 117-127

  Fissolo, Nicolas ^a   Riedl, Petra ^a   Reimann, Jörg ^a   Schirmbeck, Reinhold ^a  

^a UNIVERSITY OF ULM   (Germany)

Author keywords

Alternative open reading frames; CD8+ T cells; DNA vaccines; Gene expression; Immunodominance hierarchies

Indexed keywords

DNA VACCINE; EPITOPE; GAMMA INTERFERON; HEAT SHOCK PROTEIN 73; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; PLASMID DNA; VIRUS ANTIGEN; VIRUS PROTEIN;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN DETECTION; ANTIGEN EXPRESSION; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; DOWN REGULATION; EXPRESSION VECTOR; GENE OVEREXPRESSION; GENETIC CODE; GENETIC TRANSFECTION; HEPATITIS B VIRUS; IMMUNIZATION; IMMUNOGENICITY; MOLECULAR CLONING; MOUSE; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE ACTIVATION;

ALTERNATIVE SPLICING; ANIMALS; BASE SEQUENCE; CD8-POSITIVE T-LYMPHOCYTES; DNA, VIRAL; FEMALE; GENE EXPRESSION; GENE PRODUCTS, POL; GENOME, VIRAL; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HEPATITIS B VIRUS; IMMUNODOMINANT EPITOPES; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; OPEN READING FRAMES; PEPTIDE FRAGMENTS; PLASMIDS; PROMOTER REGIONS (GENETICS); VACCINES, DNA;

EID: 12344312103     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200425608     Document Type: Article

References (31)

1. Donnelly, J. J., Ulmer, J. B., Shiver, J. W. and Liu, M. A., DNA vaccines. Annu. Rev. Immunol. 1997. 15: 617-648.
2. Gurunathan, S., Klinman, D. M. and Seder, R. A., DNA vaccines: immunology, application and optimization. Annu. Rev. Immunol. 2000. 18: 927-974.
3. Wild, J., Grüner, B., Metzger, K., Kuhröber, A., Pudollek, H.-P., Hauser, H., Schirmbeck, R. and Reimann, J., Polyvalent vaccination against hepatitis B surface and core antigen using dicistronic expression plasmids. Vaccine 1998. 16: 353-360.
4. Kwissa, M., Unsinger, J., Schirmbeck, R., Hauser, H. and Reimann, J., Polyvalent DNA vaccines with bidirectional promoters. J. Mol. Med. 2000. 78: 495-506.
5. Böhm, W., Kuhröber, A., Paier, T., Mertens, T., Reimann, J. and Schirmbeck, R., DNA vector constructs that prime hepatitis B surface antigen-specific cytotoxic T lymphocyte and antibody responses in mice after intramuscular injection. J. Immunol. Methods 1996. 193: 29-40.
6. Galibert, F., Mandart, E., Fitoussi, F., Tiollais, P. and Charnay, P., Nucleotide sequence of the hepatitis B virus genome (subtype ayw) cloned in E. coli. Nature 1979. 281: 646-650.
7. Tiollais, P., Pourcel, C. and Dejean, A., The hepatitis B virus. Nature 1985. 317: 489-495.
8. Moolla, N., Kew, M. and Arbuthnot, P., Regulatory elements of hepatitis B virus transcription. J. Viral Hepat. 2002. 9: 323-331.
9. Heermann, K. -H. and Gerlich, W. H., Surface proteins of hepatitis B virus.In McLachlan, A. (Ed.) The molecular biology of hepatitis B virus. CRC Press, Boca Raton 1991, pp 109-132.
10. Siddiqui, A., Jameel, S. and Mapoles, J., Transcriptional control elements of hepatitis B surface antigen gene. Proc. Natl. Acad. Sci. USA 1986. 83: 566-570.
11. Vannice, J. L. and Levinson, A. D., Properties of the human hepatitis B virus enhancer: position effects and cell-type nonspecificity. J. Virol. 1988. 62: 1305-1313.
12. Yuh, C. H. and Ting, L. P., The genome of hepatitis B virus contains a second enhancer: cooperation of two elements within this enhancer is required for its function. J. Virol. 1990. 64: 4281-4287.
13. Sette, A., Vitiello, A., Reherman, B., Fowler, P., Nayersina, R., Kast, W. M., Melief, C. J., Oseroff, C., Yuan, L., Ruppert, J., Sidney, M., Guercio, S., Southwood, R., Kubo, R., Chesnut, H., Grey, F. and Chisari, F. V., The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes. J. Immunol. 1994. 153: 5586-5592.
14. Rehermann, B., Fowler, P., Sidney, J., Person, J., Redeker, A., Brown, M., Moss, B., Sette, A. and Chisari, F. V., The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis. J. Exp. Med. 1995. 181: 1047-1058.
15. Rehermann, B., Lau, D., Hoofnagle, J. H. and Chisari, F. V., Cytotoxic T lymphocyte responsiveness after resolution of chronic hepatitis B virus infection. J. Clin. Invest. 1996. 97: 1655-1665.
16. Loirat, D., Lemonnier, F. A. and Michel, M.-L., Multiepitopic HLA-A*0201-restricted immune response against hepatitis B surface antigen after DNA-based immunization. J. Immunol. 2000. 165: 4748-4755.
17. Kakimi, K., Isogawa, M., Chung, J., Sette, A. and Chisari, F. V., Immunogenicity and tolerogenicity of hepatitis B virus structural and nonstructural proteins: implications for immunotherapy of persistent viral infections. J. Virol. 2002. 76: 8609-8620.
18. + T cells specific for structural and nonstructural hepatitis B virus proteins in patients with chronic hepatitis B: implications for immunotherapy. J. Virol. 2004. 78: 5707-5719.
19. Ishikawa, T., Kono, D. H., Fowler, P., Theofilopoulos, A. N., Kakumu, S. and Chisari, F. V., Polyclonality and multispecificity of the CTL response to a single viral epitope. J. Immunol. 1998. 161: 5842-5850.
20. Sette, A., Oseroff, C., Sidney, J., Alexander, J., Chesnut, R. W., Kakimi, K., Guidotti, L. G. and Chisari, F. V., Overcoming T cell tolerance to the hepatitis B virus surface antigen in hepatitis B virus-transgenic mice. J. Immunol. 2001. 166: 1389-1397.
21. Schirmbeck, R., Wild, J. and Reimann, J., Similar as well as distinct MHC-I-binding peptides are generated by exogenous and endogenous processing of hepatitis B virus surface antigen (HBsAg). Eur. J. Immunol. 1998. 28: 4149-4161.
22. zu Putlitz, J., Lanford, R. E., Carlson, R. I., Notvall, L., de la Monte, S. M. and Wands, J. R., Properties of monoclonal antibodies directed against hepatitis B virus polymerase protein. J. Virol. 1999. 73: 4188-4196.
23. zu Putlitz, J., Encke, J. and Wands, J. R., Cytotoxic T cell responses against hepatitis B virus polymerase induced by genetic immunization. J. Hepatol. 2000. 33: 986-991.
24. b-restricted HBsAg epitopes. J. Immunol. 2002. 168: 6253-6262.
25. + T cell responses by DNA vaccines expressing stress protein-binding polytope peptides. J. Immunol. 2003. 171: 1240-1246.
26. Schirmbeck, R., Kwissa, M., Fissolo, N., Elkholy, S., Riedl, P. and Reimann, J., Priming polyvalent immunity by DNA vaccines expressing chimeric antigens with a stress protein-capturing, viral J-domain. FASEB J. 2002. 16: 1108-1110.
27. Reimann, J. and Schirmbeck, R., DNA vaccines expressing antigens with a stress protein-capturing domain display enhanced immunogenicity. Immunol. Rev. 2004. 199: 54-67.
28. Boon, T. and van Pel, A., T cell-recognized antigenic peptides derived from the cellular genome are not protein degradation products but can be generated directly by transcription and translation of short subgenic regions. A hypothesis. Immunogenetics 1989. 29: 75-79.
29. Shastri, N., Schwab, S. and Serwold, T., Producing nature's gene-chips: the generation of peptides for display by MHC class I molecules. Annu. Rev. Immunol. 2002. 20: 463-493.
30. Karasuyama, H. and Melchers, F., Establishment of mouse cell lines which constitutively secrete large quantities of interleukin 2, 3, 4 and 5, using modified cDNA expression vectors. Eur. J. Immunol. 1988. 18: 97-104.
31. Kuhröber, A., Wild, J., Pudollek, H. P., Chisari, F. V. and Reimann, J., DNA vaccination with plasmids encoding the intracellular (HBcAg) or secreted (HBeAg) form of the core protein of hepatitis B virus primes T cell responses to two overlapping Kb- and Kd-restricted epitopes. Int. Immunol. 1997. 9: 1203-1212.